Biocodex AB in Sweden is a part of the global pharmaceutical company Biocodex. With 60 years of success, we have built on the requirement of high-quality standards, both scientifically and in terms of our manufacturing process. In 1953, the year of its founding, the initial core activity of Biocodex was first gastroenterology, with an original probiotic yeast, Saccharomyces boulardii CNCM I-745®, brand name Precosa in Sweden, the first of its kind having a beneficial effect on the intestinal microflora. Today, BIOCODEX has transformed far beyond its “probiotic” roots, by deploying its product portfolio in a variety of therapeutic areas including: • gastroenterology • pain management • neurology • otolaryngology • rheumatology We also offer Pharmacovigilance, Regulatory and Medical Affairs services, as well as a wide range of GxP help such as responsible pharmacist, quality management support, auditing and training services. We provide these services in all the Nordic and Baltic markets. Our mission is to inspire wellbeing together and also provide high quality services and products to our partners worldwide and, through them, to patients. We remain humble and responsible, ensuring that all aspects of our business are conducted with integrity. Our vision is to be the preferred partner and Microbiota experts in the Nordics and Baltics. We aim to be the best in our therapeutic areas and take the quality of the services we provide to our customers to heart. The keys to our success lie in anticipating trends in medicine and developing solutions that improve the lives of patients. We act together, we believe in real partnerships. We are committed to excellence, with strong moral values and a vision for the future. Our values are translating this vision: • We dare to innovate • We care for our ecosystem • We play collective • We shape fair relations